Dashboard
Manage Tickers

BIOR


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biora-therapeutics-achieves-iso-13485-certification-demonstrating-the-cos-commitment-to-compliance-with-the-most-rigorous-global-regulatory-and-quality-standards
Biora Therapeutics Achieves ISO 13485 Cert...
09/09/2024 12:13:32

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company reimagining therapeutic delivery, today announced it has been award...

biora-therapeutics-granted-extension-to-regain-compliance-with-nasdaq-listing-requirements
Biora Therapeutics Granted Extension To Re...
08/28/2024 12:01:45

hc-wainwright--co-reiterates-buy-on-biora-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Bior...
08/13/2024 18:04:10

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

biora-therapeutics-q2-2024-gaap-eps-004-beats-045-estimate-sales-318000k-up-from-2000k-yoy
Biora Therapeutics Q2 2024 GAAP EPS $(0.04...
08/12/2024 20:38:13

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(...

biora-therapeutics-inks-financing-agreements-with-its-existing-convertible-notes-holders
Biora Therapeutics Inks Financing Agreemen...
08/12/2024 20:09:28

hc-wainwright--co-reiterates-buy-on-biora-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Bior...
07/22/2024 10:41:20

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

biora-therapeutics-announces-presentation-of-supplemental-data-from-phase-1-bt-600-trial-says-pharmacokinetic-and-tissue-data-confirm-navicap-platform-delivers-topically-through-the-entire-colon-with-lower-systemic-concentrations-as-desired
Biora Therapeutics Announces Presentation ...
07/18/2024 12:01:57

biora-therapeutics-announces-clinical-trial-results-for-bt-600
Biora Therapeutics Announces Clinical Tria...
07/01/2024 12:01:49

Drug-device combination leverages Biora's NaviCap™ platform to deliver tofacitinib directly to colonic tissue as a potentia...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/17/2024 20:31:09

biora-therapeutics-says-company-did-not-regain-compliance-with-nasdaqs-mvls-rule-by-june-10-2024
Biora Therapeutics Says Company Did Not Re...
06/14/2024 20:35:26

-SEC Filing

biora-therapeutics-says-notified-co-that-its-securities-were-subject-to-delisting-from-nasdaq-unless-company-timely-requests-hearing-before-panel
Biora Therapeutics Says Notified Co That I...
06/14/2024 20:34:36

-SEC Filing-SEC Filing

biora-therapeutics-to-present-on-the-biojet-systemic-oral-delivery-platform-at-the-next-gen-peptide-formulation--delivery-summit-2024
Biora Therapeutics To Present On The BioJe...
06/11/2024 12:06:33

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it w...

why-netease-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why NetEase Shares Are Trading Lower? Here...
05/24/2024 17:57:35

why-ross-stores-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Ross Stores Shares Are Trading Higher ...
05/24/2024 12:22:48

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/24/2024 12:07:16

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

biora-therapeutics-to-present-clinical-data-on-device-function-of-the-navicap-platform-at-digestive-disease-week-2024
Biora Therapeutics To Present Clinical Dat...
05/20/2024 12:15:49

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, presented a poster titled...

hc-wainwright--co-reiterates-buy-on-biora-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Bior...
05/16/2024 15:49:23

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $15 pr...

biora-therapeutics-q1-2024-gaap-eps-014-beats-045-estimate-sales-542000k
Biora Therapeutics Q1 2024 GAAP EPS $(0.14...
05/15/2024 20:09:49

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(...

biora-therapeutics-to-present-clinical-data-on-device-function-of-the-navicap-oral-delivery-platform-at-digestive-disease-week-2024
Biora Therapeutics To Present Clinical Dat...
05/06/2024 12:18:46

Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it w...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION